Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02255474 · ClinicalTrials.gov registry record · NA
Bifocal Lenses In Nearsighted Kids
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 294
- Enrollment target
NCT02255474 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 294 participants.
The verdict
NCT02255474, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 294 participants
- Enrollment target
Study Summary
This study will evaluate the use of two different bifocal contact lens add powers to prevent further nearsighted progression in children ages 7 to 11 years old. It is theorized that the profile of the bifocal lenses will decrease the amount of change in nearsightedness that the children experience.
Interventions
- DEVICE Biofinity Multifocal D +1.50 add
- DEVICE Biofinity Multifocal D +2.50 add
- DEVICE Biofinity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 294 participants |
| Start Date | 2014-09-22 |
| Est. Completion | 2019-06-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02255474
The ClinicalTrials.gov registry entry for NCT02255474 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 294 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Biofinity Multifocal D +1.50 add is the first listed.
NCT02255474 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02255474 about?
NCT02255474 is a clinical study titled "Bifocal Lenses In Nearsighted Kids". This study will evaluate the use of two different bifocal contact lens add powers to prevent further nearsighted progression in children ages 7 to 11 years old. It is theorized that the profile of the bifocal lenses will decrease the amount of change in nearsightedness that the children experience.
What is the current status of trial NCT02255474?
This trial is currently completed. It is a NA study. The enrollment target is 294 participants. The study started on 2014-09-22. Estimated completion is 2019-06-24.
What interventions are being tested in trial NCT02255474?
The interventions under investigation include: Biofinity Multifocal D +1.50 add (DEVICE), Biofinity Multifocal D +2.50 add (DEVICE), Biofinity (DEVICE).
Who is sponsoring clinical trial NCT02255474?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.